NCT00035100View on ClinicalTrials.gov

EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

June 30, 2003

Conditions
Ovarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms
Interventions
DRUG

epothilone b

Trial Locations (8)

08901

Novartis Investigative Site, New Brunswick

M5G 2M9

Novartis Investigative Site, Toronto

7513 ER

Novartis Investigative Site, Enschede

1066 CX

Novartis Investigative Site, Amsterdam

8025 AB

Novartis Investigative Site, Zwolle

812 50

Novartis Investigative Site, Bratislava

04190

Novartis Investigative Site, Košice

SM2 5PT

Novartis Investigative Site, Surrey

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY